Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3
2(66.7%)
Phase 4
1(33.3%)
3Total
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05018221Phase 3Recruiting

Better Evidence and Translation for Calciphylaxis

Role: collaborator

NCT02823821Phase 4Recruiting

Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

Role: collaborator

NCT03969225Completed

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis

Role: collaborator

NCT02365493Phase 3Terminated

Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection

Role: collaborator

All 4 trials loaded